News & Press

November 12, 2021

Orthogon Therapeutics Announces an $8m Follow-On Financing to Advance Its Lead BK Virus Drug

The Company is developing the first, orally available antiviral to treat one of the most common viral infections in pediatric and adult transplant patients November 8, […]
June 1, 2018

Orthogon Therapeutics Raises $4.4 Million in Series A Financing

CANTON, Mass., March 8, 2018 /PRNewswire-iReach/ — Orthogon Therapeutics, LLC, a drug design company developing a pipeline of preclinical assets, announced today the closing of a […]

Contact Us

 
 
 

960 Turnpike St., Unit 10
Canton, MA 02021
T: 339-502-9108
F: 617-849-5968
info@orthogontherapeutics.com